120 related articles for article (PubMed ID: 15710510)
1. Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100.
Moustafine RI; Kabanova TV; Kemenova VA; Van den Mooter G
J Control Release; 2005 Mar; 103(1):191-8. PubMed ID: 15710510
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of interpolyelectrolyte complexes of Eudragit E 100 with sodium alginate.
Moustafine RI; Kemenova VA; Van den Mooter G
Int J Pharm; 2005 Apr; 294(1-2):113-20. PubMed ID: 15814235
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes.
Moustafine RI; Zaharov IM; Kemenova VA
Eur J Pharm Biopharm; 2006 May; 63(1):26-36. PubMed ID: 16380241
[TBL] [Abstract][Full Text] [Related]
5. Eudragit E PO as a complementary material for designing oral drug delivery systems with controlled release properties: comparative evaluation of new interpolyelectrolyte complexes with countercharged eudragit L100 copolymers.
Moustafine RI; Bukhovets AV; Sitenkov AY; Kemenova VA; Rombaut P; Van den Mooter G
Mol Pharm; 2013 Jul; 10(7):2630-41. PubMed ID: 23777284
[TBL] [Abstract][Full Text] [Related]
6. Design of a colonic delivery system based on cationic polymethacrylate (Eudragit E100)-mesalamine complexes.
Quinteros DA; Manzo RH; Allemandi DA
Drug Deliv; 2010 May; 17(4):208-13. PubMed ID: 20230248
[TBL] [Abstract][Full Text] [Related]
7. Structural transformations during swelling of polycomplex matrices based on countercharged (meth)acrylate copolymers (Eudragit EPO/Eudragit L 100-55).
Moustafine RI; Bobyleva VL; Bukhovets AV; Garipova VR; Kabanova TV; Kemenova VA; Van Den Mooter G
J Pharm Sci; 2011 Mar; 100(3):874-85. PubMed ID: 20803617
[TBL] [Abstract][Full Text] [Related]
8. Interaction and complex formation between catalase and cationic polyelectrolytes: chitosan and Eudragit E100.
Boeris V; Romanini D; Farruggia B; Picó G
Int J Biol Macromol; 2009 Aug; 45(2):103-8. PubMed ID: 19397924
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Eudragit E100/Carbomer 940P interpolyelectrolyte complexes using swellability measurements.
Kabanova TV; Zhdanova ER; Moustafine RI
J Control Release; 2006 Nov; 116(2):e33-5. PubMed ID: 17718956
[No Abstract] [Full Text] [Related]
10. Spray-dried lipid-hyaluronan-polymethacrylate microparticles for drug delivery in the peritoneum.
Domnina YA; Yeo Y; Tse JY; Bellas E; Kohane DS
J Biomed Mater Res A; 2008 Dec; 87(3):825-31. PubMed ID: 18257078
[TBL] [Abstract][Full Text] [Related]
11. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
12. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
13. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
[TBL] [Abstract][Full Text] [Related]
14. Interpolyelectrolyte complexes of Eudragit E PO with sodium alginate as potential carriers for colonic drug delivery: monitoring of structural transformation and composition changes during swellability and release evaluating.
Moustafine RI; Salachova AR; Frolova ES; Kemenova VA; Van den Mooter G
Drug Dev Ind Pharm; 2009 Dec; 35(12):1439-51. PubMed ID: 19929203
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
16. pH-sensitive microparticles for oral drug delivery based on alginate/oligochitosan/Eudragit(®) L100-55 "sandwich" polyelectrolyte complex.
Calija B; Cekić N; Savić S; Daniels R; Marković B; Milić J
Colloids Surf B Biointerfaces; 2013 Oct; 110():395-402. PubMed ID: 23751419
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release.
Prado HJ; Matulewicz MC; Bonelli PR; Cukierman AL
Carbohydr Res; 2009 Jul; 344(11):1325-31. PubMed ID: 19539898
[TBL] [Abstract][Full Text] [Related]
18. Floating and sustained-release characteristics of effervescent tablets prepared with a mixed matrix of Eudragit L-100-55 and Eudragit E PO.
Bani-Jaber AK; Alkawareek MY; Al-Gousous JJ; Abu Helwa AY
Chem Pharm Bull (Tokyo); 2011; 59(2):155-60. PubMed ID: 21297292
[TBL] [Abstract][Full Text] [Related]
19. A novel pH-responsive interpolyelectrolyte hydrogel complex for the oral delivery of levodopa. Part I. IPEC modeling and synthesis.
Ngwuluka NC; Choonara YE; Kumar P; du Toit LC; Khan RA; Pillay V
J Biomed Mater Res A; 2015 Mar; 103(3):1077-84. PubMed ID: 24909427
[TBL] [Abstract][Full Text] [Related]
20. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
